Skip to main content
Article
Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure
American Journal of Nephrology (2018)
  • Andrew Bostom, Rhode Island Hospital
  • Dominik Steubl, Technische Universität München
  • Pranav S. Garimella, University of California, San Diego
  • Nora Franceschini, University of North Carolina at Chapel Hill
  • Mary B. Roberts, Memorial Hospital of Rhode Island
  • Andreas Pasch, University of Bern
  • Joachim H. Ix, University of California, San Diego
  • Katherine R. Tuttle, University of Washington
  • Anastasia Ivanova, University of North Carolina at Chapel Hill
  • Theresa Shireman, Brown University
  • S. Joseph Kim, Toronto General Hospital
  • Reginald Gohh, Brown University
  • Daniel E. Weiner, Tufts Medical Center
  • Andrew S. Levey, Tufts Medical Center
  • Chi-yuan Hsu, University of California, San Francisco
  • John W. Kusek, National Institutes of Health
  • Charles B. Eaton, Brown University
Publication Date
January 1, 2018
DOI
10.1159/000489095
Citation Information
Andrew Bostom, Dominik Steubl, Pranav S. Garimella, Nora Franceschini, et al.. "Serum Uromodulin: A Biomarker of Long-Term Kidney Allograft Failure" American Journal of Nephrology Vol. 47 Iss. 4 (2018) p. 275 - 282
Available at: http://works.bepress.com/katherine-tuttle/143/